Autosomal Dominant Polycystic Kidney Disease and Inherited Cystic Diseases

Seldin and Giebisch's The Kidney

Volumn , Issue , 2008, Pages 2283-2313

  Somlo, Stefan ^b   Torres, Vicente E ^a   Caplan, Michael J ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 38849143453     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088488-9.50084-X     Document Type: Chapter

References (392)

1. Abderrahim E., Hedri H., Laabidi J., Raies L., Kheder A., Abdallah T.B., Moussa F.B., Maiz H.B. Chronic subdural haematoma and autosomal polycystic kidney disease: report of two new cases. Nephrology (Carlton) 2004, 9:331-333.
2. Aguiari G., Manzati E., Penolazzi L., Micheletti F., Augello G., Vitali E.D., Cappelli G., Cai Y., Reynolds D., Somlo S., Piva R., del Senno L. Mutations in autosomal dominant polycystic kidney disease 2 gene: reduced expression of PKD2 protein in lymphoblastoid cells. Am J Kidney Dis 1999, 33:880-885.
3. Ahringer J. Control of cell polarity and mitotic spindle positioning in animal cells. Curr Opin Cell Biol 2003, 15:73-81.
4. Alehan F.K., Gurakan B., Agildere M. Familial arachnoid cysts in association with autosomal dominant polycystic kidney disease. Pediatrics 2002, 110:e13.
5. Alpern M.B., Dorfman R.E., Gross B.H., Gottlieb C.A., Sandler M.A. Seminal vesicle cysts: association with adult polycystic kidney disease. Radiology 1991, 180:79-80.
6. Alvaro D., Mancino M.G., Onori P., Franchitto A., Alpini G., Francis H., Glaser S., Gaudio E. Estrogens and the pathophysiology of the biliary tree. World J Gastroenterol 2006, 12:3537-3545.
7. Anyatonwu G.I., Estrada M., Tian X., Somlo S., Ehrlich B.E. Regulation of ryanodine receptordependent calcium signaling by polycystin-2. Proc Natl Acad Sci U S A 2007, 104:6454-6459.
8. Astrinidis A., Henske E.P. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease. Oncogene 2005, 24:7475-7481.
9. Badano J.L., Mitsuma N., Beales P.L., Katsanis N. The ciliopathies: an emerging class of human genetic disorders. Annu Rev Genomics Hum Genet 2006, 7:125-148.
10. Badano J.L., Teslovich T.M., Katsanis N. The centrosome in human genetic disease. Nat Rev Genet 2005, 6:194-205.
11. Bae K.T., Zhu F., Guay-Woodford L.M., Chapman A.B., Torres V.E., Grantham J.J., Baumgarten D., King B.F., Wetzel L.H., Kenney P., Brummer M.E., Bennett W.M., Klahr S., Meyers C.M.N., Zhang X., Thompson P.A., Miller A. CRISP. ]Magnetic resonance imaging evaluation of hepatic cysts in early autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2006, 1:64-69.
12. Baena-Lopez L.A., Baonza A., Garcia-Bellido A. The orientation of cell divisions determines the shape of Drosophila organs. Curr Biol 2005, 15:1640-1644.
13. Baert L. Hereditary polycystic kidney disease (adult form): a microdissection study of two cases at an early stage of the disease. Kidney Int 1978, 13:519-525.
14. Bajwa Z.H., Gupta S., Warfield C.A., Steinman T.I. Pain management in polycystic kidney disease. Kidney Int 2001, 60:1631-1644.
15. Bajwa Z.H., Sial K.A., Malik A.B., Steinman T.I. Pain patterns in patients with polycystic kidney disease. Kidney Int 2004, 66:1561-1569.
16. Barr M.M., DeModena J., Braun D., Nguyen C.Q., Hall D.H., Sternberg P.W. The Caenorhabditis elegans autosomal dominant polycystic kidney disease gene homologs lov-1 and pkd-2 act in the same pathway. Curr Biol 2001, 11:1341-1346.
17. Barr M.M., Sternberg P.W. A polycystic kidney disease gene homolog required for male mating behavior in Caenorhabiditis elegans. Nature 1999, 401:386-389.
18. Basar O., Ibis M., Ucar E., Ertugrul I., Yolcu O.F., Koklu S., Parlak E., Ulker A. Recurrent pancreatitis in a patient with autosomal-dominant polycystic kidney disease. Pancreatology 2006, 6:160-162.
19. Bateman A., Sandford R. The PLAT domain: a new piece in the PKD1 puzzle. Curr Biol 1999, 9:R588-R590.
20. Belibi F.A., Reif G., Wallace D.P., Yamaguchi T., Olsen L., Li H., Helmkamp G.M., Grantham J.J. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int 2004, 66:964-973.
21. Bello-Reuss E., Holubec K., Rajaraman S. Angiogenesis in autosomal-dominant polycystic kidney disease. Kidney Int 2001, 60:37-45.
22. Bhunia A.K., Piontek K., Boletta A., Liu L., Qian F., Xu P.N., Germino F.J., Germino G.G. PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 2002, 109:157-168.
23. Bisgrove B.W., Yost H.J. The roles of cilia in developmental disorders and disease. Development 2006, 133:4131-4143.
24. Bleeker-Rovers C.P., de Sevaux R.G., van Hamersvelt H.W., Corstens F.H., Oyen W.J. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2003, 41:18-21.
25. Boca M., Distefano G., Qian F., Bhunia A.K., Germino G.G., Boletta A. Polycystin-1 induces resistance to apoptosis through the phosphatidylinositol 3-kinase/Akt signaling pathway. J Am Soc Nephrol 2006, 17:637-647.
26. Boletta A., Qian F., Onuchic L.F., Bhunia A.K., Phakdeekitcharoen B., Hanaoka K., Guggino W., Monaco L., Germino G.G. Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells. Mol Cell 2000, 6:1267-1273.
27. Boletta A., Qian F., Onuchic L.F., Bragonzi A., Cortese M., Deen P.M., Courtoy P.J., Soria M.R., Devuyst O., Monaco L., Germino G.G. Biochemical characterization of bona fide polycystin-1 in vitro and in vivo. Am J Kidney Dis 2001, 38:1421-1429.
28. Boulter C., Mulroy S., Webb S., Fleming S., Brindle K., Sandford R. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene. Proc Natl Acad Sci U S A 2001, 98:12174-12179.
29. Brasier J.L., Henske E.P. Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. J Clin Invest 1997, 99:194-199.
30. Brembeck F.H., Rosario M., Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 2006, 16:51-59.
31. Brill S.R., Ross K.E., Davidow C.J., Ye M., Grantham J.J., Caplan M.J. Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells. Proc Natl Acad Sci U S A 1996, 93:206-10211. 10.
32. Brown M.S., Ye J., Rawson R.B., Goldstein J.L. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 2000, 100:391-398.
33. Bukanov N., Smith L.A., Klinger K., Ledbetter S.R., Ibraghimov-Beskrovnaya O. Long lasting arrest of murine polycystic kidney disease with CDK inhibitor R-Roscovitine. Nature 2006, 444:949-952.
34. Butscheid Y., Chubanov V., Steger K., Meyer D., Dietrich A., Gudermann T. Polycystic kidney disease and receptor for egg jelly is a plasma membrane protein of mouse sperm head. Mol Reprod Dev 2006, 73:350-360.
35. Bycroft M., Bateman A., Clarke J., Hamill S.J., Sandford R., Thomas R.L., Chothia C. The structure of a PKD domain from polycystin-1: implications for polycystic kidney disease. EMBO J 1999, 18:297-305.
36. Cai Y., Anyatonwu G., Okuhara D., Lee K.B., Yu Z., Onoe T., Meic L., Qian Q., Geng L., Wiztgall R., Ehrlich B.E., Somlo S. Calcium dependence of polycystin-2 channel activity is modulated by phosphorylation at Ser812. J Biol Chem 2004, 279:19987-19995.
37. Cai Y., Maeda Y., Cedzich A., Torres V.E., Wu G., Hayashi T., Mochizuki T., Park J.H., Witzgall R., Somlo S. Identification and characterization of polycystin-2, the PKD2 gene product. J Biol Chem 1999, 274:28557-28565.
38. Calvet J.P. Polycystic kidney disease: primary extracellular matrix abnormality or defective cellular differentiation?. Kidney Int 1993, 43:101-108.
39. Calvet J.P., Grantham J.J. The genetics and physiology of polycystic kidney disease. Semin Nephrol 2001, 21:107-123.
40. Chapman A.B., Johnson A., Gabow P.A., Schrier R.W. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 1990, 323:1091-1096.
41. Chapman A.B., Rubinstein D., Hughes R., Stears J.C., Earnest M.P., Johnson A.M., Gabow P.A., Kaehny W.D. Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med 1992, 327:916-920.
42. Chapman A., Guay-Woodford L.J.J.G., Torres V., Bae K., Baumgarten D., Kenney P., King B., Glockner J., Wetzel L., Brummer M., O'Neill C., Robbin M., Bennett W., Klahr S., Hirschman G., Kimmel P., Thompson P., Miller J. Renal structure in early autosomal dominant polycystic kidney disease (ADPKD); the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRI. Kidney Int 2003, 64:1035-1045.
43. Chauvet V., Tian X., Husson H., Grimm D.H., Wang T., Hieseberger T., Igarashi P., Bennett A.M., Ibraghimov-Beskrovnaya O., Somlo S., Caplan M.J. Mechanical s.timuli induce cleavage and nuclear translocation of the polycystin-1 C terminus. J Clin Invest 2004, 114:1433-1443.
44. Clausen P., Feldt-Rasmussen B., Iversen J., Lange M., Eidemak I., Strandgaard S. Flowassociated dilatory capacity of the brachial artery is intact in early autosomal dominant polycystic kidney disease. Am J Nephrol 2006, 26:335-339.
45. Corbit K.C., Aanstad P., Singla V., Norman A.R., Stainier D.Y., Reiter J.F. Vertebrate Smoothened functions at the primary cilium. Nature 2005, 437:1018-10121.
46. D'Alessio C., Fernandez F., Trombetta E.S., Parodi A.J. Genetic evidence for the heterodimeric structure of glucosidase II: the effect of disrupting the subunit-encoding genes on glycoprotein folding. J Biol Chem 1999, 274:25899-25905.
47. Danaci M., Akpolat T., Bastemir M., Sarikaya S., Akan H., Selcuk M.B., Cengiz K. The prevalence of seminal vesicle cysts in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 1998, 13:2825-2828.
48. Davenport J.R., Yoder B.K. An incredible decade for the primary cilium: a look at a onceforgotten organelle. Am J Physiol Renal Physiol 2005, 289:1159-1169.
49. Davila S., Furu L., Gharavi A.G., Tian X., Onoe T., Qian Q., Li A., Cai Y., Kamath P.S., King B.F., Azurmendi P.J., Tahvanainen P., Kaariainen H., Hockerstedt K., Devuyst O., Pirson Y., Martin R.S., Lifton R.P., Tahvanainen E., Torres V.E., Somlo S. Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet 2004, 36:575-577.
50. Davis E.E., Brueckner M., Katsanis N. The emerging complexity of the vertebrate cilium: new functional roles for an ancient organelle. Dev Cell 2006, 11:9-19.
51. De R.ycke M., Georgiou I., Sermon K., Lissens W., Henderix P., Joris H., Platteau P., Van Steirteghem A., Liebaers I. PGD for autosomal dominant polycystic kidney disease type 1. Mol Hum Reprod 2005, 11:65-71.
52. Delmas P. Polycystins: polymodal receptor/ion-channel cellular sensors. Pflugers Arch 2005, 451:264-276.
53. Delmas P., Nomura H., Li X., Lakkis M., Luo Y., Segal Y., Fernandez-Fernandez J.M., Harris P., Frischauf A.M., Brown D.A., Zhou J. Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2. J Biol Chem 2002, 277:11276-11283.
54. Dobin A., Kimberling W.J., Pettinger W., Bailey-Wilson J.E., Shugart Y.Y., Gabow P. Segregation analysis of autosomal dominant polycystic kidney disease. Genet Epidemiol 1993, 10:189-200.
55. Doulton T.W., Saggar-Malik A.K., He F.J., Carney C., Markandu N.D., Sagnella G.A., MacGregor G.A. The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney patients. J Hypertens 2006, 24:939-945.
56. Drenth J.P., Te Morsche R.H., Smink R., Bonifacino J.S., Jansen J.B. Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. Nat Genet 2003, 10:10.
57. Ecder T., Chapman A., Brosnahan G., Edelstein C., Johnson A., Schrier R. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2000, 35:427-432.
58. Eley L., Turnpenny L., Yates L.M., Craighead A.S., Morgan D., Whistler C., Goodship J.A., Strachan T. A perspective on inversin. Cell Biol Int 2004, 28:119-124.
59. Ellgaard L., Molinari M., Helenius A. Setting the standards: quality control in the secretory pathway. Science 1999, 286:1882-1888.
60. Elzinga L.W., Bennett W.M. Miscellaneous renal and systemic complications of autosomal dominant polycystic kidney disease including infection. Polycystic Kidney Disease 1996, 483-499. Oxford Medical Publications, Oxford, UK. M.L. Watson, V.E. Torres (Eds.).
61. Fabris L., Cadamuro M., Fiorotto R., Roskams T., Spirlic Melero S., Sonzogni A., Joplin R.E., Okolicsanyi L., Strazzabosco M. Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases. Hepatology 2006, 43:1001-1012.
62. Fagotto F., Funayama N., Gluck U., Gumbiner B.M. Binding to cadherins antagonizes the signaling activity of beta-catenin during axis formation in Xenopus. J Cell Biol 1996, 132:1105-1114.
63. Fain P.R., McFann K.K., Taylor M.R., Tison M., Johnson A.M., Reed B., Schrier R.W. Modifier genes play a significant role in the phenotypic expression of PKD1. Kidney Int 2005, 67:1256-1267.
64. Fanto M., McNeill H. Planar polarity from flies to vertebrates. J Cell Sci 2004, 117:527-533.
65. Fick G.M., Johnson A.M., Hammond W.S., Gabow P.A. Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1995, 5:2048-2056.
66. Fick-Brosnahan G.M., Belz M.M., McFann K.K., Johnson A.M., Schrier R.W. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study. Am J Kidney Dis 2002, 39:1127-1134.
67. Fischer E., Legue E., Doyen A., Nato F., Nicolas J.F., Torres V., Yaniv M., Pontoglio M. Defective planar cell polarity in polycystic kidney disease. Nat Genet 2006, 38:21-23.
68. Foggensteiner L., Bevan A.P., Thomas R., Coleman N., Boulter C., Bradley J., Ibraghimov-Beskrovnaya O., Klinger K., Sandford R. Cellular and subcellular distribution of polycystin-2, the protein product of the PKD2 gene. J Am Soc Nephrol 2000, 11:814-827.
69. Follit J.A., Tuft R.A., Fogarty K.E., Pazour G.J. The intraflagellar transport protein IFT20 is associated with the Golgicomplex and is required for cilia assembly. Mol Biol Cell 2006, 17:3781-3792.
70. Forman J.R., Qamar S., Paci E., Sandford R.N., Clarke J. The remarkable mechanical strength of polycystin-1 supports a direct role in mechanotransduction. J Mol Biol 2005, 349:861-871.
71. Gabow P.A., Chapman A.B., Johnson A.M., Tangel D.J., Duley I.T., Kaehny W.D., Manco-Johnson M., Schrier R.W. Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int 1990, 38:1177-1180.
72. Gabow P., Johnson A., Kaehny W., Kimberling W., Lezotte D., Duley I., Jones R. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 1992, 41:1311-1319.
73. Gabow P., Johnson A., Kaehny W., Manco-Johnson M., Duley I., Everson G. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 1990, 11:1033-1037.
74. Gallagher A.R., Cedzich A., Gretz N., Somlo S., Witzgall R. The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton. Proc Natl Acad Sci U S A 2000, 97:4017-4022.
75. Gao Z., Joseph E., Ruden D.M., Lu X. Drosophila Pkd2 is haploid-insufficient for mediating optimal smooth muscle contractility. J Biol Chem 2004, 279:14225-14231.
76. Gao Z., Ruden D.M., Lu X. PKD2 cation channel is required for directional sperm movement and male fertility. Curr Biol 2003, 13:2175-2178.
77. Gattone V.H., Maser R.L., Tian C., Rosenberg J.M., Branden M.G. Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. Develop Gen 1999, 24:309-318.
78. Gattone V.H., Wang X., Harris P.C., Torres V.E. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nature Med 2003, 9:1323-1326.
79. Geberth St., Ritz E., Zeier M., Stier E. Anticipation of age at renal death in autosomal dominant polycystic kidney disease (ADPKD)?. Nephrol Dial Transplant 1995, 10:1603-1606.
80. Geng L., Burrow C.R., Li H.P., Wilson P.D. Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation. Biochim Biophys Acta 2000, 1535:21-35.
81. Geng L., Okuhara D., Yu Z., Tian X., Cai Y., Shibazaki S., Somlo S. Polycystin-2 traffics to cilia independently of polycystin-1 by using an N-terminal RVxP motif. J Cell Sci 2006, 119:1383-1395.
82. Geng L., Segal Y., Pavlova A., Barros E.J., Lohning C., Lu W., Nigam S.K., Frischauf A.M., Reeders S.T., Zhou J. Distribution and developmentally regulated expression of murine polycystin. Am J Physiol 1997, 272:F451-F459.
83. Geng L., Segal Y., Peissel B., Deng N., Pei Y., Carone F., Rennke H.G., Glucksmann-Kuis A.M., Schneider M.C., Ericsson M., Reeders S.T., Zhou J. Identification and localization of polycystin, the PKD1 gene product. J Clin Invest 1996, 98:2674-2682.
84. Germino G.G. Linking cilia to Wnts. Nat Genet 2005, 37:455-457.
85. Giles R.H., van Es J.H., Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003, 1653:1-24.
86. Gong Y., Mo C., Fraser S.E. Planar cell polarity signalling controls cell division orientation during zebrafish gastrulation. Nature 2004, 430:689-693.
87. Gonzalez-Perrett S., Kim K., Ibarra C., Damiano A.E., Zotta E., Batelli M., Harris P.C., Reisin I.L., Arnaout M.A., Cantiello H.F. Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. PNAS 2001, 98:1182-1187.
88. Gottardic J., Gumbiner B.M. Adhesion signaling: how beta-catenin interacts with its partners. Curr Biol 2001, 11:792-794.
89. Graham P.C., Lindop G.B. The anatomy of the renin-secreting cell in adult polycystic kidney disease. Kidney Int 1988, 33:1084-1090.
90. Grampsas S.A., Chandhoke P.S., Fan J., Glass M.A., Townsend R., Johnson A.M., Gabow P. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2000, 36:53-57.
91. Grantham J.J., Torres V.E., Chapman A.B., Guay-Woodford L.M., Bae K.T., King B.F., Wetzel L.H., Baumgarten D.A., Kenney P.J., Harris P.C., Klahr S., Bennett W.M., Hirschman G.N., Meyers C.M., Zhang X., Zhu F., Miller J.P. Volume progression in polycystic kidney disease. N Engl J Med 2006, 354:2122-2130.
92. Grantham J.J., Wallace D.P. Return of the secretory kidney. Am J Physiol Renal Physiol 2002, 282:1-9.
93. Grantham J., Cowley B., Torres V. Progression of autosomal dominant polycystic kidney disease (ADPKD) to renal failure. The Kidney: Physiology and Pathophysiology 2000, 2513-2536. Lippincott Williams & Wilkins, Philadelphia. D. Seldin, G. Giebisch (Eds.).
94. Gregoire J., Torres V., Holley K., Farrow G. Renal epithelial hyperplastic and neoplastic proliferation in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1987, 9:27-38.
95. Gresh L., Fischer E., Reimann A., Tanguy M., Garbay S., Shao X., Hiesberger T., Fiette L., Igarashi P., Yaniv M., Pontoglio M. A transcriptional network in polycystic kidney disease. EMBO J 2004, 23:1657-1668.
96. Griffin M.D., Torres V.E., Grande J.P., Kumar R. Vascular expression of polycystin. J Am Soc Nephrol 1997, 8:616-626.
97. Grimm D.H., Cai Y., Chauvet V., Rajendran V., Zeltner R., Geng L., Avner E.D., Sweeney W., Somlo S., Caplan M.J. Polycystin-1 distribution is modulated by polycystin-2 expression in mammalian cells. J Biol Chem 2003, 278:36786-36793.
98. Grimm D.H., Karihaloo A., Cai Y., Somlo S., Cantley L.G., Caplan M.J. Polycystin-2 regulates proliferation and branching morphogenesis in kidney epithelial cells. J Biol Chem 2006, 281:137-144.
99. Grunfeld J.P., Albouze G., Jungers P., Landais P., Dana A., Droz D., Moynot A., Lafforgue B., Boursztyn E., Franco D. Liver changes and complications in adult polycystic kidney disease. Adv Nephrol Necker Hosp 1985, 14:1-20.
100. Guay-Woodford L. Autosomal recessive polycystic kidney disease. The Genetics of Renal Disease 2003, 239-251. Oxford University Press, Oxford, UK. F. Flinter, A. Saggar-Malik (Eds.).
101. Guay-Woodford L.M. Murine models of polycystic kidney disease: molecular and therapeutic insights. Am J Physiol Renal Physiol 2003, 285:F1034-F1049.
102. Hanaoka K., Qian F., Boletta A., Bhunia A.K., Piontek K., Tsiokas L., Sukhatme V.P., Guggino W.B., Germino G.G. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 2000, 408:990-994.
103. Harris P.C., Bae K.T., Rossetti S., Torres V.E., Grantham J.J., Chapman A.B., Guay-Woodford L.M., King B.F., Wetzel L.H., Baumgarten D.A., Kenney P.J., Consugar M., Klahr S., Bennett W.M., Meyers C.M., Zhang Q.J., Thompson P.A., Zhu F., Miller J.P. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2006, 17:3013-3019.
104. Harris P.C., Thomas S., MacCarthy A.B., Stallings R.L., Breuning M.H., Jenne D.E., Fink T.M., Buckle V.J., Ratcliffe P.J., Ward C.J. A large duplicated area in the polycystic kidney disease 1 (PKD1) region of chromosome 16 is prone to rearrangement. Genomics 1994, 23:321-330.
105. Hart M.J., de los Santos R., Albert I.N., Rubinfeld B., Polakis P. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol 1998, 8:573-581.
106. Hateboer N., Dijk M.A., Bogdanova N., Coto E., Saggar-Malik A.K., San Millan J.L., Torra R., Breuning M., Ravine D. Comparison of phenotypes of polycystic kidney disease types 1 and 2 . European PKD1-PKD2 Study Group. Lancet 1999, 353:103-107.
107. Hateboer N., Lazarou L.P., Williams A.J., Holmans P., Ravine D. Familial phenotype differences in PKD1. Kidney Int 1999, 56:34-40.
108. Haycraft C.J., Banizs B., Aydin-Son Y., Zhang Q., Michaud E.J., Yoder B.K. Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function. PLoS Genet 2005, 1:e53.
109. Heasman J., Crawford A., Goldstone K., Garner-Hamrick P., Gumbiner B., McCrea P., Kintner C., Noro C.Y., Wylie C. Overexpression of cadherins and underexpression of beta-catenin inhibit dorsal mesoderm induction in early Xenopus embryos. Cell 1994, 79:791-803.
110. Heinonen P.K., Vuento M., Maunola M., Ala-Houhala I. Ovarian manifestations in women with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2002, 40:504-507.
111. Helenius A., Aebi M. Intracellular functions of N-linked glycans. Science 2001, 291:2364-2369.
112. Hidaka S., Konecke V., Osten L., Witzgall R. PIGEA-14, a novel coiled-coil protein affecting the intracellular distribution of polycystin-2. J Biol Chem 2004, 279:35009-35016.
113. Hiesberger T., Bai Y., Shao X., McNally B.T., Sinclair A.M., Tian X., Somlo S., Igarashi P. Mutation of hepatocyte nuclear factor-1b inhibits Pkhd1 gene expression and produces renal cysts in mice. J Clin Invest 2004, 113:814-825.
114. Hillman K.A., Woolf A.S., Johnson T.M., Wade A., Unwin R.J., Winyard P.J. The P2X7 ATP receptor modulates renal cyst development in vitro. Biochem Biophys Res Commun 2004, 322:434-439.
115. Hooper K.M., Boletta A., Germino G.G., Hu Q., Ziegelstein R.C., Sutters M. Expression of polycystin-1 enhances endoplasmic reticulum calcium uptake and decreases capacitative calcium entry in ATP-stimulated MDCK cells. Am J Physiol Renal Physiol 2005, 289:521-530.
116. Hossack K.F., Leddy C.L., Johnson A.M., Schrier R.W., Gabow P.A. Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med 1988, 319:907-912.
117. Hu J., Bae Y.K., Knobel K.M., Barr M.M. Casein kinase II and calcineurin modulate TRPP function and ciliary localization. Mol Biol Cell 2006, 17:2200-2211.
118. Hu J., Barr M.M. ATP-2 interacts with the PLAT domain of LOV-1 and is involved in Caenorhabditis elegans polycystin signaling. Mol Biol Cell 2005, 16:458-469.
119. Huan Y., van Adelsberg J. Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J Clin Invest 1999, 104:1459-1468.
120. Huang A.L., Chen X., Hoon M.A., Chandrashekar J., Guo W., Trankner D., Ryba N.J., Zuker C.S. The cells and logic for mammalian sour taste detection. Nature 2006, 442:934-938.
121. Hughes J., Ward C.J., Aspinwall R., Butler R., Harris P.C. Identification of a human homologue of the sea urchin receptor for egg jelly: a polycystic kidney disease-like protein. Hum Mol Genet 1999, 8:543-549.
122. Hughes J., Ward C.J., Peral B., Aspinwall R., Clark K., San Millan J.L., Gamble V., Harris P.C. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 1995, 10:151-160.
123. Ibraghimov-Beskrovnaya O., Bukanov N.O., Donohue L.C., Dackowski W.R., Klinger K.W., Landes G.M. Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant polycystic kidney disease gene, PKD1. Hum Mol Genet 2000, 9:1641-1649.
124. Ibraghimov-Beskrovnaya O., Dackowski W.R., Foggensteiner L., Coleman N., Thiru S., Petry L.R., Burn T.C., Connors T.D., Van Raay T., Bradley J., Qian F., Onuchic L.F., Watnick T.J., Piontek K., Hakim R.M., Landes G.M., Germino G.G., Sandford R., Klinger K.W. Polycystin: In vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci U S A 1997, 94:6397-6402.
125. Iglesias C.G., Torres V.E., Offord K.P., Holley K.E., Beard C.M., Kurland L.T. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota. Am J Kidney Dis 1983, 2:630-639.
126. Inagawa T. Trends in incidence and case fatality rates of aneurysmal subarachnoid hemorrhage in Izumo City, Japan, between 1980-1989 and 1990-1998. Stroke 2001, 32:1499-1507.
127. Ishibe S., Joly D., Zhu X., Cantley L.G. Phosphorylation-dependent paxillin-ERK association mediates hepatocyte growth factor-stimulated epithelial morphogenesis. Mol Cell 2003, 12:1275-1285.
128. Ishikawa I., Chikamoto E., Nakamura M., Asaka M., Tomosugi N., Yuri T. High incidence of common bile duct dilatation in autosomal dominant polycystic kidney disease patients. Am J Kidney Dis 1996, 27:321-326.
129. Ishimaru Y., Inada H., Kubota M., Zhuang H., Tominaga M., Matsunami H. Transient receptor potential family members PKD1L3 and PKD2L1 form a candidate sour taste receptor. Proc Natl Acad Sci U S A 2006, 103:12569-12574.
130. Jenkins P.M., Hurd T.W., Zhang L., McEwen D.P., Brown R.L., Margolis B., Verhey K.J., Martens J.R. Ciliary targeting of olfactory CNG channels requires the CNGB1b subunit and the kinesin-2 motor protein, KIF17. Curr Biol 2006, 16:1211-1216.
131. Jiang S.T., Chiou Y.Y., Wang E., Lin H.K., Lin Y.T., Chi Y.C., Wang C.K., Tang M.J., Li H. Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1. Am J Pathol 2006, 168:205-220.
132. Johnson A., Gabow P. Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol 1997, 8:1560-1567.
133. Joly D., Berissi S., Bertrand A., Strehl L., Patey N., Knebelmann B. Laminin 5 regulates polycystic kidney cell proliferation and cyst formation. J Biol Chem 2006, 281:29181-29189.
134. Joly D., Ishibe S., Nickel C., Yu Z., Somlo S., Cantley L.G. The polycystin 1-C-terminal fragment stimulates ERK-dependent spreading of renal epithelial cells. J Biol Chem 2006, 281:26329-26339.
135. Jones C., Chen P. Planar cell polarity signaling in vertebrates. Bioessays 2007, 29:120-132.
136. Karim R., Tse G., Putti T., Scolyer R., Lee S. The significance of the Wnt pathway in the pathology of human cancers. Pathology 2004, 36:120-128.
137. Keith D., Torres V., King B., Zincki H., Farrow G. Renal cell carcinoma in autosomal dominant polycystic kidney disease (Review). J Am Soc Nephrol 1994, 4:1661-1669.
138. Kelleher C.L., McFann K.K., Johnson A.M., Schrier R.W. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population. Am J Hypertens 2004, 17:1029-1034.
139. Kielstein R., Sass H.M. Genetics in kidney disease: how much do we want to know?. Am J Kidney Dis 2002, 39:637-652.
140. Kim E., Arnould T., Sellin L., Benzing T., Comella N., Kocher O., Tsiokas L., Sukhatme V.P., Walz G. Interaction between RGS7 and polycystin. Proc Natl Acad Sci U S A 1999, 96:6371-6376.
141. Kim E., Arnould T., Sellin L.K., Benzing T., Fan M.J., Gruning W., Sokol S.Y., Drummond I., Walz G. The polycystic kidney disease 1 gene product modulates Wnt signaling. J Biol Chem 1999, 274:4947-4953.
142. Kim K., Drummond I., Ibraghimov-Beskrovnaya O., Klinger K., Arnaout M.A. Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A 2000, 97:1731-1736.
143. King B.F., Reed J.E., Bergstralh E.J., Sheedy P.F., Torres V.E. Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease. J Am Soc Neph 2000, 11:1505-1511.
144. i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: Relevance to the ADPKD phenotype. Circ Res 2005, 96:873-880.
145. Kiselyov K., Soyombo A., Muallem S. TRPpathies. J Physiol 2007, 578:641-653.
146. Klahr S., Breyer J., Beck G., Dennis V., Hartman J., Roth D., Steinman T., Wang S., Yamamoto M. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease modification of diet in renal disease study group. J Am Soc Nephrol 1995, 5:2037-2047.
147. Klein I.H., Ligtenberg G., Oey P.L., Koomans H.A., Blankestijn P.J. Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. J Am Soc Nephrol 2001, 12:2427-2433.
148. Kleymenova E., Ibraghimov-Beskrovnaya O., Kugoh H., Everitt J., Xu H., Kiguchi K., Landes G., Harris P., Walker C. Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene. Mol Cell 2001, 7:823-832.
149. Kocaman O., Oflaz H., Yekeler E., Dursun M., Erdogan D., Demirel S., Alisir S., Turgut F., Mercanoglu F., Ecder T. Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2004, 43:854-860.
150. Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 2005, 6:827-837.
151. Koptides M., Mean R., Demetriou K., Pierides A., Delta S.C.C. Genetic evidence for a transheterozygous model for cystogenesis in autosomal dominant polycystic kidney disease. Hum Mol Genet 2000, 9:447-552.
152. Kottgen M., Benzing T., Simmen T., Tauber R., Buchholz B., Feliciangeli S., Huber T.B., Schermer B., Kramer-Zucker A., Hopker K., Simmen K.C., Tschucke C.C., Sandford R., Kim E., Thomas G., Walz G. Trafficking of TRPP2 by PACS proteins represents a novel mechanism of ion channel regulation. EMBO J 2005, 24:705-716.
153. Koulen P., Cai Y., Geng L., Maeda Y., Nishimura S., Witzgall R., Ehrlich B.E., Somlo S. Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol 2002, 4:191-197.
154. Krasnoperov V., Lu Y., Buryanovsky L., Neubert T.A., Ichtchenko K., Petrenko A.G. Posttranslational proteolytic processing of CIRL, a natural chimera of cell adhesion protein and G protein-coupled receptor. The role of the GPS motif. J Biol Chem 2002, 277:46518-46526.
155. Kumar S., Adeva M., King B.F., Kamath P.S., Torres V.E. Duodenal diverticulosis in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2006, 21:3576-3578.
156. Lantinga-van Leeuwen I.S., Dauwerse J.G., Baelde H.J., Leonhard W.N., van de W.A., Ward C.J., Verbeek S., Deruiter M.C., Breuning M.H., de H.E., Peters D.J. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum Mol Genet 2004, 13:3069-3077.
157. Le N.H., van der Bent P., Huls G., van de Wetering M., Loghman-Adham M., Ong A.C., Calvet J.P., Clevers H., Breuning M.H., van Dam H., Peters D.J. Aberrant polycystin-1 expression results in modification of activator protein-1 activity, whereas Wnt signaling remains unaffected. J Biol Chem 2004, 279:27472-27481.
158. Lederman E.D., McCoy G., Conti D.J., Lee E.C. Diverticulitis and polycystic kidney disease. Am Surg 2000, 66:200-203.
159. Lehtonen S., Ora A., Olkkonen V.M., Geng L., Zerial M., Somlo S., Lehtonen E. In vivo interaction of the adapter protein CD2-associated protein with the type 2 polycystic kidney disease protein, polycystin-2. J Biol Chem 2000, 275:32888-32893.
160. Lehtonen S., Zhao F., Lehtonen E. CD2-associated protein directly interacts with the actin cytoskeleton. Am J Physiol Renal Physiol 2002, 283:F734-F743.
161. Leier C.V., Baker P.B., Kilman J.W., et al. Cardiovascular abnormalities associated with adult polycystic kidney disease. Ann Int Med 1984, 100:683-688.
162. Leuenroth S.J., Okuhara D., Shotwell J.D., Markowitz G.S., Yu Z., Somlo S., Crews C.M. Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proc Natl Acad Sci U S A 2007, 104:4389-4394.
163. Li V.ecchi M., Cianfrone P., Damiano R., Fuiano G. Infertility in adults with polycystic kidney disease. Nephrol Dial Transplant 2003, 18:190-191.
164. Li A., Davila S., Furu L., Qian Q., Tian X., Kamath P.S., King B.F., Torres V.E., Somlo S. Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am J Hum Genet 2003, 72:691-703.
165. Li A., Tian X., Sung S.W., Somlo S. Identification of two novel polycystic kidney disease 1-like genes in human and mouse genomes. Genomics 2003, 82:498-500.
166. Li H., Findlay I.A., Sheppard D.N. The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors. Kidney Int 2004, 66:1926-1938.
167. Li H.P., Geng L., Burrow C.R., Wilson P.D. Identification of phosphorylation sites in the PKD1-encoded protein C-terminal domain. Biochem Biophys Res Commun 1999, 259:356-363.
168. Li Q., Dai Y., Guo L., Liu Y., Hao C., Wu G., Basora N., Michalak M., Chen X.Z. Polycystin-2 associates with tropomyosin-1, an actin microfilament component. J Mol Biol 2003, 325:949-962.
169. Li Q., Montalbetti N., Shen P.Y., Dai X.Q., Cheeseman C.I., Karpinski E., Wu G., Cantiello H.F., Chen X.Z. Alpha-actinin associates with polycystin-2 and regulates its channel activity. Hum Mol Genet 2005, 14:1587-1603.
170. Li Q., Shen P.Y., Wu G., Chen X.Z. Polycystin-2 interacts with troponin I, an angiogenesis inhibitor. Biochemistry 2003, 42:450-457.
171. Li X., Luo Y., Starremans P.G., McNamara C.A., Pei Y., Zhou J. Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2. Nat Cell Biol 2005, 7:1202-1212.
172. 2+ signaling. J Biol Chem 2005, 280:41298-41306.
173. Lin F., Hiesberger T., Cordes K., Sinclair A.M., Goldstein L.S., Somlo S., Igarashi P. Kidney specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease. Proc Natl Acad Sci U S A 2003, 100:5286-5291.
174. Liu S., Lu W., Obara T., Kuida S., Lehoczky J., Dewar K., Drummond I.A., Beier D.R. A defect in a novel Nek-family kinase causes cystic kidney disease in the mouse and in zebrafish. Development 2002, 129:5839-5846.
175. 2+ concentration is attenuated in collecting duct of monociliumimpaired orpk mice. Am J Physiol Renal Physiol 2005, 289:F978-F988.
176. Loghman-Adham M., Soto C.E., Inagami T., Cassis L. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am J Physiol Renal Physiol 2004, 287:775-788.
177. Lopez Jimenez N.D., Cavenagh M.M., Sainz E., Cruz-Ithier M.A., Battey J.F., Sullivan S.L. Two members of the TRPP family of ion channels, Pkd1l3 and Pkd2l1, are co-expressed in a subset of taste receptor cells. J Neurochem 2006, 98:68-77.
178. Low S.H., Vasanth S., Larson C.H., Mukherjee S., Sharma N., Kinter M.T., Kane M.E., Obara T., Weimbs T. Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. Dev Cell 2006, 10:57-69.
179. Lu W., Peissel B., Babakhanlou H., Pavlova A., Geng L., Fan X., Larson C., Brent G., Zhou J. Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation. Nat Genet 1997, 17:179-181.
180. Lu W., Shen X., Pavlova A., Lakkis M., Ward C.J., Pritchard L., Harris P.C., Genest D.R., Perez-Atayde A.R., Zhou J. Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum Mol Genet 2001, 10:2385-2396.
181. Lumiaho A., Ikaheimo R., Miettinen R., Niemitukia L., Laitinen T., Rantala A., Lampainen E., Laakso M., Hartikainen J. Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1. Am J Kidney Dis 2001, 38:1208-1216.
182. 2+-permeable cation channel in renal epithelia. Mol Cell Biol 2003, 23:2600-2607.
183. Ma R., Li W.P., Rundle D., Kong J., Akbarali H.I., Tsiokas L. PKD2 functions as an epidermal growth factor-activated plasma membrane channel. Mol Cell Biol 2005, 25:8285-8298.
184. Magenheimer B.S., St John P.L., Isom K.S., Abrahamson D.R., De Lisle R.C., Wallace D.P., Maser R.L., Grantham J.J., Calvet J.P. Early embryonic renal tubules of wildtype and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+), K(+), 2Cl(-) Co-transporter-dependent cystic dilation. J Am Soc Nephrol 2006, 17:3424-3437.
185. Magistroni R., He N., Wang K., Andrew R., Johnson A., Gabow P., Dicks E., Parfrey P., Torra R., San-Millan J.L., Coto E., Van Dijk M., Breuning M., Peters D., Bogdanova N., Ligabue G., Albertazzi A., Hateboer N., Demetriou K., Pierides A., Deltas C., St George-Hyslop P., Ravine D., Pei Y. Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2003, 14:1164-1174.
186. Mahjoub M.R., Qasim Rasi M., Quarmby L.M. A NIMA-related kinase, Fa2p, localizes to a novel site in the proximal cilia of Chlamydomonas and mouse kidney cells. Mol Biol Cell 2004, 15:5172-5186.
187. Mahjoub M.R., Trapp M.L., Quarmby L.M. NIMA-related kinases defective in murine models of polycystic kidney diseases localize to primary cilia and centrosomes. J Am Soc Nephrol 2005, 16:3485-3489.
188. Mamane Y., Petroulakis E., LeBacquer O., Sonenberg N. mTOR, translation initiation and cancer. Oncogene 2006, 25:6416-6422.
189. Markowitz G.S., Cai Y., Li L., Wu G., Ward L.C., Somlo S., D'Agati V.D. Polycystin-2 expression is developmentally regulated. Am J Physiol 1999, 277:F17-F25.
190. Marshall W.F., Nonaka S. Cilia: tuning in to the cell's antenna. Curr Biol 2006, 16:R604-R614.
191. Martin G.M., Ogburn C.E., Colgin L.M., Gown A.M., Edland S.D., Monnat R.J. Somatic mutations are frequent and increase with age in human kidney epithelial cells. Hum Mol Genet 1996, 5:215-221.
192. Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., et al. The sequence and analysis of duplication-rich human chromosome 16. Nature 2004, 432:988-994.
193. Masyuk T.V., Masyuk A.I., Torres V.E., Harris P.C., LaRusso N.F. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3', 5'-cyclic monophosphate. Gastroenterology 2007, 132:1104-1116.
194. Matsumura M.E., Lobe D.R., McNamara C.A. Contribution of the helix-loop-helix factor Id2 to regulation of vascular smooth muscle cell proliferation. J Biol Chem 2002, 277:7293-7727.
195. McCune T.R., Nylander W.A., Van Buren D.H., Richie R.E., MacDonell R.C., Johnson H.K., Shull H., Cate C.K., Helderman J.H. Colonic screening prior to renal transplantation and its impact on post-transplant colonic complications. Clin Transplant 1992, 6:91-96.
196. McGrath J., Somlo S., Makova S., Tian X., Brueckner M. Two populations of node monocilia initiate left-right asymmetry in the mouse. Cell 2003, 114:61-73.
197. McPherson E.A., Luo Z., Brown R.A., LeBard L.S., Corless C.C., Speth R.C., Bagby S.P. Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2004, 15:493-500.
198. Menezes L.F., Cai Y., Nagasawa Y., Silva A.M., Watkins M.L., Da Silva A.M., Somlo S., Guay-Woodford L.M., Germino G.G., Onuchic L.F. Polyductin, the PKHD1 gene product, comprises isoforms expressed in plasma membrane, primary cilium, and cytoplasm. Kidney Int 2004, 66:1345-1355.
199. Mengerink K.J,, Moy G.W., Vacquier V.D. suREJ3, a polycystin-1 protein, is cleaved at the GPS domain and localizes to the acrosomal region of sea urchin sperm. J Biol Chem 2002, 277:943-948.
200. Milutinovic J., Fialkow P.J., Agodoa L.Y., Phillips L.A., Bryant J.I. Fertility and pregnancy complications in women with autosomal dominant polycystic kidney disease. Obstet Gynecol 1983, 61:566-569.
201. Milutinovic J., Rust P.F., Fialkow P.J., Agodoa L.Y., Phillips L.A., Rudd T.G., Sutherland S. Intrafamilial phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis 1992, 19:465-472.
202. Mochizuki T., Saijoh Y., Tsuchiya K., Shirayoshi Y., Takai S., Taya C., Yonekawa H., Yamada K., Nihei H., Nakatsuji N., Overbeek P.A., Hamada H., Yokoyama T. Cloning of inv, a gene that controls left/right asymmetry and kidney development. Nature 1998, 395:177-181.
203. Mochizuki T., Wu G., Hayashi T., Xenophontos S.L., Veldhuisen B., Saris J.J., Reynolds D.M., Cai Y., Gabow P.A., Pierides A., Kimberling W.J., Breuning M.H., DeltaS C.C., Peters D.J., Somlo S. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996, 272:1339-1342.
204. Moon R.T. Canonical Wnt/beta-catenin pathway. Sci STKE 2004, 240:tr 5.
205. Moy G.W., Mendoza L.M., Schulz J.R., Swanson W.J., Glabe C.G., Vacquier V.D. The sea urchin sperm receptor for egg jelly is a modular protein with extensive homology to the human polycystic kidney disease protein, PKD1. J Cell Biol 1996, 133:809-817.
206. Mumm J.S., Schroeter E.H., Saxena M.T., Griesemer A., Tian X., Pan D.J., Ray W.J., Kopan R. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell 2000, 5:197-206.
207. Murcia N.S., Richards W.G., Yoder B.K., Mucenski M.L., Dunlap J.R., Woychik R.P. The Oak Ridge Polycystic Kidney (orpk) disease gene is required for left-right axis determination. Development 2000, 127:2347-2355.
208. Muto S., Aiba A., Saito Y., Nakao K., Nakamura K., Tomita K., Kitamura T., Kurabayashi M., Nagai R., Higashihara E., Harris P.C., Katsuki M., Horie S. Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant. Hum Mol Genet 2002, 11:1731-1742.
209. Mykytyn K., Sheffield V.C. Establishing a connection between cilia and Bardet-Biedl syndrome. Trends Mol Med 2004, 10:106-109.
210. Nagao S., Yamaguchi T., Kusaka M., Maser R.L., Takahashi H., Cowley B.D., Grantham J.J. Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease. Kidney Int 2003, 63:427-437.
211. Nagao S., Kazuhiro N., Katsuyama M., Kurahashi H., Marunouchi T., Takahashi H., Wallace D.P. Increased water intake decreases progression of polycystic kidney disease in the PCK rat. J Am Soc Nephrol 2006, 17:228-235.
212. Naitoh H., Shoji H., Ishikawa I., Watanabe R., Furuta Y., Tomozawa S., Igarashi H., Shinozaki S., Katsura H., Onozato R., Kudoh M. Intraductal papillary mucinous tumor of the pancreas associated with autosomal dominant polycystic kidney disease. J Gastrointest Surg 2005, 9:843-845.
213. Nauli S.M., Alenghat F.J., Luo Y., Williams E., Vassilev P., Li X., Elia A.E., Lu W., Brown E.M., Quinn S.J., Ingber D.E., Zhou J. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 2003, 33:129-137.
214. Neill A.T., Moy G.W., Vacquier V.D. Polycystin-2 associates with the polycystin-1 homolog, suREJ3, and localizes to the acrosomal region of sea urchin spermatozoa. Mol Reprod Dev 2004, 67:472-477.
215. Newby L.J., Streets A.J., Zhao Y., Harris P.C., Ward C.J., Ong A.C. Identification, characterization, and localization of a novel kidney polycystin-1-polycystin-2 complex. J Biol Chem 2002, 277:20763-20773.
216. Nichols M.T., Gidey E., Matzakos T., Dahl R., Stiegmann G., Shah R.J., Grantham J.J., Fitz J.G., Doctor R.B. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid. Hepatology 2004, 40:836-846.
217. Nicolau C., Torra R., Bianchi L., Vilana R., Gilabert R., Darnell A., Bru C. Abdominal sonographic study of autosomal dominant polycystic kidney disease. J Clin Ultrasound 2000, 28:277-282.
218. Nilius B., Owsianik G., Voets T., Peters J.A. Transient receptor potential cation channels in disease. Physiol Rev 2007, 87:165-217.
219. Nims N., Vassmer D., Maser R.L. Transmembrane domain analysis of polycystin-1, the product of the polycystic kidney disease-1 (PKD1) gene: evidence for 11 membrane-spanning domains. Biochemistry 2003, 42:13035-13048.
220. Nishio S., Hatano M., Nagata M., Horie S., Koike T., Tokuhisa T., Mochizuki T. Pkd1 regulates immortalized proliferation of rean tubular epithelial cells through p53 induction and JNK activation. J Clin Invest 2005, 115:910-918.
221. Nomura H., Turco A.E., Pei Y., Kalaydjieva L., Schiavello T., Weremowicz S., Ji W., Morton C.C., Meisler M., Reeders S.T., Zhou J. Identification of PKDL, a novel polycystic kidney disease 2-like gene whose murine homologue is deleted in mice with kidney and retinal defects. J Biol Chem 1998, 273:25967-25973.
222. O'Sullivan D., Torres V., Gabow P., Thibodeau S., King B., Bergstralh E. Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis 1998, 32:976-983.
223. Obara T., Mangos S., Liu Y., Zhao J., Wiessner S., Kramer-Zucker A.G., Olale F., Schier A.F., Drummond I.A. Polycystin-2 immunolocalization and function in zebrafish. J Am Soc Nephrol 2006, 17:2706-2718.
224. Obermuller N., Gallagher A.R., Cai Y., Cedzich A., Gassler N., Somlo S., Witzgall R. The rat Pkd2 protein assumes distinct subcellular distributions in different organs. Am J Physiol 1999, 277:F914-F925.
225. Okada H., Ban S., Nagao S., Takahashi H., Suzuki H., Neilson E.G. Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int 2000, 58:587-597.
226. Okada H., Fujioka H., Tatsumi N., Fujisawa M., Gohji K., Arakawa S., Kato H., Kobayashi S., Isojima S., Kamidono S. Assisted reproduction for infertile patients with 9 + 0 immotile spermatozoa associated with autosomal dominant polycystic kidney disease. Hum Reprod 1999, 14:110-113. [published erratum appears in Hum Reprod 1999;14:1166].
227. Omori S., Hida M., Fujita H., Takahashi H., Tanimura S., Kohno M., Awazu M. Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease. J Am Soc Nephrol 2006, 17:1604-1614.
228. Ong A.C., Harris P.C. Molecular basis of renal cyst formation-one hit or two?. Lancet 1997, 349:1039-1040.
229. Ong A.C., Harris P.C., Davies D.R., Pritchard L., Rossetti S., Biddolph S., Vaux D.J., Migone N., Ward C.J. Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissue. Kidney Int 1999, 56:1324-1333.
230. Ong A.C., Ward C.J., Butler R.J., Biddolph S., Bowker C., Torra R., Pei Y., Harris P.C. Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue. Am J Pathol 1999, 154:1721-1729.
231. Onuchic L.F., Furu L., Nagasawa Y., Hou X., Eggermann T., Ren Z., Bergmann C., Senderek J., Esquivel E., Zeltner R., Rudnik-Schoneborn S., Mrug M., Sweeney W., Avner E.D, Zerres K., Guay-Woodford L.M., Somlo S., Germino G.G. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor dom parallel beta-helix 1 repeats. Am J Hum Genet 2002, 70:1305-1317.
232. Palsson R., Sharma C.P., Kim K., McLaughlin M., Brown D., Arnaout M.A. Characterization and cell distribution of polycystin, the product of autosomal dominant polycystic kidney disease gene 1. Mol Med 1996, 2:702-711.
233. Park T.J., Haigo S.L., Wallingford J.B. Ciliogenesis defects in embryos lacking inturned or fuzzy function are associated with failure of planar cell polarity and Hedgehog signaling. Nat Genet 2006, 38:303-311.
234. Parnell S.C., Magenheimer B.S., Maser R.L., Calvet J.P. Identification of the major site of in vitro PKA phosphorylation in the polycystin-1 C-terminal cytosolic domain. Biochem Biophys Res Commun 1999, 259:539-543.
235. Parnell S.C., Magenheimer B.S., Maser R.L., Rankin C.A., Smine A., Okamoto T., Calvet J.P. The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric Gproteins in vitro. Biochem Biophys Res Commun 1998, 251:625-631.
236. Parnell S.C., Magenheimer B.S., Maser R.L., Zien C.A., Frischauf A.M., Calvet J.P. Polycystin-1 activation of c-Jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins. J Biol Chem 2002, 277:19566-19572.
237. Paterson A.D., Magistroni R., He N., Wang K., Johnson A., Fain P.R., Dicks E., Parfrey P., St George-Hyslop P., Pei Y. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2005, 16:755-762.
238. Paterson A.D., Pei Y. Is there a third gene for autosomal dominant polycystic kidney disease?. Kidney Int 1998, 54:1759-1761.
239. Paterson A.D., Wang K.R., Lupea D., St George-Hyslop P., Pei Y. Recurrent fetal loss associated with bilineal inheritance of type 1 autosomal dominant polycystic kidney disease. Am J Kidney Dis 2002, 40:16-20.
240. Pazour G.J. Intraflagellar transport and cilia-dependent renal disease:the ciliary hypothesis of polycystic kidney disease. J Am Soc Nephrol 2004, 15:2528-2536.
241. Pazour G.J., Dickert B.L., Vucica Y., Seeley E.S., Rosenbaum J.L., Witman G.B., Cole D.G. Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella. J Cell Biol 2000, 151:709-718.
242. Pazour G.J., San Agustin J.T., Follit J.A., Rosenbaum J.L., Witman G.B. Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease. Curr Biol 2002, 12:R378-R380.
243. Peden E.M., Barr M.M. The KLP-6 kinesin is required for male mating behaviors and polycystin localization in Caenorhabditis elegans. Curr Biol 2005, 15:394-404.
244. Pei Y., Paterson A.D., Wang K.R., He N., Hefferton D., Watnick T., Germino G.G., Parfrey P., Somlo S., St George-Hyslop P. Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease. Am J Hum Genet 2001, 68:355-363.
245. Pei Y., Watnick T., He N., Wang K., Liang Y., Parfrey P., Germino G., St George-Hyslop P. Somatic PKD2 mutations in individual kidney and liver cysts support a 'two-hit' model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1999, 10:1524-1529.
246. Pennekamp P., Karcher C., Fischer A., Schweickert A., Skryabin B., Horst J., Blum M., Dworniczak B. The ion channel polycystin-2 is required for left-right axis determination in mice. Curr Biol 2002, 12:938-943.
247. Peral B., Gamble V., Strong C., Ong A.C., Sloane-Stanley J., Zerres K., Winearls C.G., Harris P.C. Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach. Am J Hum Genet 1997, 60:1399-1410.
248. Peral B., Ong A.C., San Millan J.L., Gamble V., Rees L., Harris P.C. A stable, nonsense mutation associated with a case of infantile onset polycystic kidney disease 1 (PKD1). Hum Mol Genet 1996, 5:539-542.
249. Pereira T.V., Nunes A.C., Rudnicki M., Magistroni R., Albertazzi A., Pereira A.C., Krieger J.E. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis. Nephrol Dial Transplant 2006, 21:3155-3163.
250. Persu A., Duyme M., Pirson Y., Lens X.M., Messiaen T., Breuning M.H., Chauveau D., Levy M., Grunfeld J.P., Devuyst O. Comparison between siblings and twins supports a role for modifier genes in ADPKD. Kidney Int 2004, 66:2132-2136.
251. Peters D.J.M., Sandkuijl L.A. Genetic heterogeneity of polycystic kidney disease in Europe. Contributions to Nephrology: Polycystic Kidney Disease 1992, 128-139. Karger, Basel. M.H. Breuining, M. Devoto, G. Romeo (Eds.).
252. Peters D.J.M., van de Wal A., Spruit L., Saris J.J., Breuning M.H., Bruijn J.A., de Heer E. Cellular localization and tissue distribution of polycystin-1. J Pathol 1999, 188:439-446.
253. Piontek K.B., Huso D.L., Grinberg A., Liu L., Bedja D., Zhao H., Gabrielson K., Qian F., Meic Westphal H., Germino G.G. A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. J Am Soc Nephrol 2004, 15:3035-3043.
254. Pirson Y., Chauveau D., Torres V.E. Management of cerebral aneurysms in autosomal dominant polycystic kidney disease: unruptured asymptomatic intracranial aneurysms. J Am Soc Nephrol 2002, 13:269-276.
255. Ponting C.P., Hofmann K., Bork P. A latrophilin/CL-1-like GPS domain in polycystin-1. Curr Biol 1999, 9:R585-R588.
256. 2+-sensitive intermediate-conductance K+ channels in MDCK cells. J Membr Biol 2003, 191:193-200.
257. Praetorius H.A., Spring K.R. Bending the MDCK cell primary cilium increases intracellular calcium. J Membr Biol 2001, 184:71-79.
258. Praetorius H.A., Spring K.R. Removal of the MDCK cell primary cilium abolishes flow sensing. J Membr Biol 2003, 191:69-76.
259. Praetorius H.A., Spring K.R. The renal cell primary cilium functions as a flow sensor. Curr Opin Nephrol Hypertens 2003, 12:517-520.
260. Praetorius H.A., Spring K.R. A physiological view of the primary cilium. Annu Rev Physiol 2005, 67:515-529.
261. Pritchard L., Sloane-Stanley J.A., Sharpe J., Aspinwall R., Lu W., Buckle V., Strmecki L., Walker D., Ward C.J., Alpers C.E., Zhou J., Wood W.G., Harris P.C. A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype. Hum Mol Genet 2000, 9:2617-2627.
262. Puri S., Magenheimer B.S., Maser R.L., Ryan E.M., Zien C.A., Walker D.D., Wallace D.P., Hempson S.J., Calvet J.P. Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway. J Biol Chem 2004, 279:55455-55464.
263. Qian C.N., Knol J., Igarashi P., Lin F., Zylstra U., Teh B.T., Williams B.O. Cystic renal neoplasia following conditional inactivation of apc in mouse renal tubular epithelium. J Biol Chem 2005, 280:3938-3945.
264. Qian F., Boletta A., Bhunia A.K., Xu H., Liu L., Ahrabi A.K., Watnick T.J., Zhou F., Germino G.G. Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutati. Proc Natl Acad Sci U S A 2002, 99:16981-16986.
265. Qian F., Germino F.J., Cai Y., Zhang X., Somlo S., Germino G.G. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet 1997, 16:179-183.
266. Qian F., Watnick T.J., Onuchic L.F., Germino G.G. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 1996, 87:979-987.
267. Qian F., Wei W., Germino G., Oberhauser A. The nanomechanics of polycystin-1 extracellular region. J Biol Chem 2005, 280:40723-40730.
268. Qian Q., Hunter L.W., Han Y.S., Ren Q., Torres V.E., Kip N.S., Farrugia G., Sieck G.C. Pkd2+/- vascular smooth muscles develop exaggerated vasocontraction in response to phenylephrine stimulation. JASN 2007, 18:485-493.
269. Qian Q., Hunter L.W., Li M., Marin-Padilla M., Prakash Y.S., Somlo S., Harris P.C., Torres V.E., Sieck G.C. Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells. Hum Mol Genet 2003, 12:1875-1880.
270. Qian Q., Li A., King B.F., Kamath P.S., Lager D.J., Huston J., Shub C., Davila S., Somlo S., Torres V.E. Clinical profile of autosomal dominant polycystic liver disease. Hepatology 2003, 37:164-171.
271. Qian Q., Li M., Cai Y., Ward C.J., Somlo S., Harris P.C., Torres V.E. Analysis of the polycystins in aortic vascular smooth muscle cells. J Am Soc Nephrol 2003, 14:2280-2287.
272. Qian Q., Younge B.R., Torres V.E. Retinal arterial and venous occlusions in patients with ADPKD. Nephrol Dial Transplant 2007, 22:1769-1776.
273. Quarmby L.M., Parker J.D. Cilia and the cell cycle?. J Cell Biol 2005, 169:707-710.
274. Ravine D., Gibson R.N., Walker R.G., Sheffield L.J., Kincaid-Smith P., Danks D.M. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994, 343:824-827.
275. Renal Data System US. USRDS 1999 Annual Data Report. Bethesda: National Institutes of Health.
276. Reynolds D.M., Falk C.T., Li A.R., King B.F., Kamath P.S., Huston J., Shub C., Iglesias D.M., Martin R.S., Pirson Y., Torres V.E., Somlo S. Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1. Am J Hum Genet 2000, 67:1598-1604.
277. Reynolds D.M., Hayashi T., Cai Y., Veldhuisen B., Watnick T.J., Lens X.M., Mochizuki T., Qian F., Maeda Y., Li Z., Fossdal R., Coto E., Wu G.Q., Breuning M.H., Germino G.G., Peters D.J.M., Somlo S. Aberrant splicing in the PKD2 gene as a cause of polycysitic kidney disease. J Am Soc Nephrol 1999, 10:2342-2351.
278. Riordan J.R., Forbush B.3., Hanrahan J.W. The molecular basis of chloride transport in shark rectal gland. J Exp Biol 1994, 196:405-418.
279. Roitbak T., Ward C.J., Harris P.C., Bacallao R., Ness S.A., Wandinger-Ness A. A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells. Mol Biol Cell 2004, 15:1334-1346.
280. Ross A.J., May-Simera H., Eichers E.R., Kai M., Hill J., Jagger D.J., Leitch C.C., Chapple J.P., Munro P.M., Fisher S., Tan P.L., Phillips H.M., Leroux M.R., Henderson D.J., Murdoch J.N., Copp A.J., Eliot M.M., Lupski J.R., Kemp D.T., Dollfus H., Tada M., Katsanis N., Forge A., Beales P.L. Disruption of Bardet-Biedl syndrome ciliary proteins perturbs planar cell polarity in vertebrates. Nat Genet 2005, 37:1135-1140.
281. Rossetti S., Burton S., Strmecki L., Pond G.R., San Millan J.L., Zerres K., Barratt T.M., Ozen S., Torres V.E., Bergstralh E.J., Winearls C.G., Harris P.C. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol 2002, 13:1230-1237.
282. Rossetti S., Chauveau D., Kubly V., Slezak J.M., Saggar-Malik A.K., Pei Y., Ong A.C., Stewart F., Watson M.L., Bergstralh E.J., Winearls C.G., Torres V.E., Harris P.C. Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 2003, 361:2196-2201.
283. Rossetti S., Strmecki L., Gamble V., Burton S., Sneddon V., Peral B., Roy S., Bakkaloglu A., Komel R., Winearls C.G., Harris P.C. Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications. Am J Hum Genet 2001, 68:46-63.
284. Ruggenenti P., Remuzzi A., Ondei P., Fasolini G., Antiga L., Ene-lordache B., Remuzzi G., Epstein F.H. Safety and efficacy of long-acting somatostatin treatment in autosomal dominant polcysytic kidney disease. Kidney Int 2005, 68:206-216.
285. Rundle D.R., Gorbsky G., Tsiokas L. PKD2 interacts and co-localizes with mDia1 to mitotic spindles of dividing cells: role of mDia1 IN PKD2 localization to mitotic spindles. J Biol Chem 2004, 279:29728-29739.
286. Saadi-Kheddouci S., Berrebi D., Romagnolo B., Cluzeaud F., Peuchmaur M., Kahn A., Vandewalle A., Perret C. Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene. Oncogene 2001, 20:5972-5981.
287. Sakurai Y., Shoji M., Matsubara T., Ochiai M., Funabiki T., Urano M., Mizoguchi Y., Fuwa N. Pancreatic ductal adenocarcinoma associated with Potter type III cystic disease. J Gastroenterol 2001, 36:422-428.
288. Sampson J.R., Maheshwar M.M., Aspinwall R., Thompson P., Cheadle J.P., Ravine D., Roy S., Haan E., Bernstein J., Harris P.C. Renal cystic disease in tuberous sclerosis: the role of the polycystic kidney disease 1 gene. Am J Hum Genet 1997, 61:843-851.
289. Sandford R., Sgotto B., Aparicio S., Brenner S., Vaudin M., Wilson R., Chissoe S., Pepin K., Bateman A., Chothia C., Hughes J., Harris P. Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains. Hum Mol Genet 1997, 6:1483-1489.
290. Sarbassov D.D., Ali S.M., Sabatini D.M. Growing roles for the mTOR pathway. Curr Opin Cell Biol 2005, 17:596-603.
291. Sasaki M., Katayanagi K., Watanabe K., Takasawa K., Nakanuma Y. Intrahepatic cholangiocarcinoma arising in autosomal dominant polycystic kidney disease. Virchows Arch 2002, 441:98-100.
292. Scheff R.T., Zuckerman G., Harter H., et al. Diverticular disease in patients with chronic renal failure due to polycystic kidney disease. Ann Int Med 1980, 92:202-204.
293. Scheffers M.S., Le H., van der B.P., Leonhard W., Prins F., Spruit L., Breuning M.H., de Heer E., Peters D.J. Distinct subcellular expression of endogenous polycystin-2 in the plasma membrane and Golgi apparatus of MDCK cells. Hum Mol Genet 2002, 11:59-67.
294. Scheffers M.S., van der B.P., Prins F., Spruit L., Breuning M.H., Litvinov S.V., de Heer E., Peters D.J. Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells. Hum Mol Genet 2000, 9:2743-2750.
295. Schievink W., Huston J., Torres V., Marsh W. Intracranial cysts in autosomal dominant polycystic kidney disease. J Neurosurg 1995, 83:1004-1007.
296. Schievink W., Torres V. Spinal meningeal diverticula in autosomal dominant polycystic kidney disease. Lancet 1997, 26:349.
297. Schnell D.J., Hebert D.N. Protein translocons: multifunctional mediators of protein translocation across membranes. Cell 2003, 112:491-505.
298. Schottenfeld J., Sullivan-Brown J., Burdine R.D. Zebrafish curly up encodes a Pkd2 ortholog that restricts left-side-specific expression of southpaw. Development 2007, 134:1605-1615.
299. Schroeter E.H., Kisslinger J.A., Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 1998, 393:382-386.
300. Seeman T., Dusek J., Vondrichova H., Kyncl M., John U., Misselwitz J., Janda J. Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease. Blood Press Monit 2003, 8:107-110.
301. Seifert J.R., Mlodzik M. Frizzled/PCP signalling: a conserved mechanism regulating cell polarity and directed motility. Nat Rev Genet 2007, 8:126-138.
302. Serafini F.M., Carey L.C. Adenoma of the ampulla of Vater: a genetic condition?. HPB Surg 1999, 11:191-193.
303. Shannon M.B., Patton B.L., Harvey S.J., Miner J.H. A hypomorphic mutation in the mouse laminin alpha5 gene causes polycystic kidney disease. J Am Soc Nephrol 2006, 17:1913-1922.
304. Sharp C.K., Zeligman B.E., Johnson A.M., Duley I., Gabow P.A. Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease. Am J Kidney Dis 1999, 34:863-868.
305. Sheppard D.N., Welsh M.J. Structure and function of the CFTR chloride channel. Physiol Rev 1999, 79:23-45.
306. Sherstha R., McKinley C., Russ P., Scherzinger A., Bronner T., Showalter R., Everson G. Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology 1997, 26:1282-1286.
307. Shillingford J.M., Murcia N.S., Larson C.H., Low S.H., Hedgepeth R., Brown N., Flask C.A., Novick A.C., Goldfarb D.A., Kramer-Zucker A., Walz G., Piontek K.B., Germino G.G., Weimbs T. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A 2006, 103:5466-5471.
308. Simons M., Gloy J., Ganner A., Bullerkotte A., Bashkurov M., Kronig C., Schermer B., Benzing T., Cabello O.A., Jenny A., Mlodzik M., Polok B., Driever W., Obara T., Walz G. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat Genet 1905, 37:537-543.
309. Singla V., Reiter J.F. The primary cilium as the cell's antenna: signaling at a sensory organelle. Science 2006, 313:629-633.
310. Siroky B.J., Ferguson W.B., Fuson A.L., Xie Y., Fintha A., Komlosi P., Yoder B.K., Schwiebert E.M., Guay-Woodford L.M., Bell P.D. Loss of primary cilia results in deregulated and unabated apical calcium entry in ARPKD collecting duct cells. Am J Physiol Renal Physiol 2006, 290:1320-1328.
311. Sise C., Kusaka M., Wetzel L.H., Winklhofer F., Cowley B.D., Cook L.T., Gordon M., Grantham J.J. Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography. Kidney Int 2000, 58:2492-2501.
312. Somlo S. The PKD2 gene: structure, interactions, mutations, and inactivation. Adv Nephrol Necker Hosp 1999, 29(257):257-275.
313. Stamm E.R., Townsend R.R., Johnson A.M., Garg K., Manco-Johnson M., Gabow P.A. Frequency of ovarian cysts in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 1999, 34:120-124.
314. Stengel B., Billon S., Van Dijk P.C., Jager K.J., Dekker F.W., Simpson K., Briggs J.D. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant 2003, 18:1824-1833.
315. Sujansky E., Kreutzer S.B., Johnson A.M., Lezotte D.C., Schrier R.W., Gabow P.A. Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease. Am J Med Genet 1990, 35:510-515.
316. Sullivan L.P., Wallace D.P., Grantham J.J. Chloride and fluid secretion in polycystic kidney disease. J Am Soc Nephrol 1998, 9:903-991.
317. Sullivan L.P., Wallace D.P., Grantham J.J. Epithelial transport in polycystic kidney disease. Physiol Rev 1998, 78:1165-1191.
318. Sun Z., Amsterdam A., Pazour G.J., Cole D.G., Miller M.S., Hopkins N. A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development 2004, 131:4085-4093.
319. Sweeney W.E., Chen Y., Nakanish K., Frost P., Avner E.D. Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney
320. Tada M., Concha M.L., Heisenberg C.P. Non-canonical Wnt signalling and regulation of gastrulation movements. Semin Cell Dev Biol 2002, 13:251-260.
321. Tahvanainen P., Tahvanainen E., Reijonen H., Halme L., Kaariainen H., Hockerstedt K. Polycystic liver disease is genetically heterogeneous: clinical and linkage studies in eight Finnish families. J Hepatol 2003, 38:39-43.
322. Tanaka Y., Okada Y., Hirokawa N. FGF-induced vesicular release of Sonic hedgehog and retinoic acid in leftward nodal flow is critical for left-right determination. Nature 2005, 435:172-177.
323. Tao Y., Kim J., Schrier R.W., Edelstein C.L. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol 2005, 16:46-51.
324. Tazon-Vega B., Vilardell M., Perez-Oller L., Ars E., Ruiz P., Devuyst O., Lens X., Fernandez-Llama P., Ballarin J., Torra R. Study of candidate genes affecting the progression of renal disease in autosomal dominant polycystic kidney disease type 1. Nephrol Dial Transplant 2007, 22:1567-1577.
325. Telenti A., Torres V., Gross J., Van Scoy R., Brown M., Hattery R. Hepatic cyst infection in autosomal dominant polycystic kidney disease. Mayo Clin Proc 1990, 65:933-942.
326. The American PKD1 Consortium Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease gene (PKD1) predicts the presence of a leucine-rich repeat. Hum Mol Genet 1995, 4:575-582.
327. The European Polycystic Kidney Disease Consortium The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosme 16. Cell 1994, 77:881-894.
328. The International Polycystic Kidney Disease Consortium Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 1995, 81:289-298.
329. Thivierge C., Kurbegovic A., Couillard M., Guillaume R., Cote O., Trudel M. Overexpression of PKD1 causes polycystic kidney disease. Mol Cell Biol 2006, 26:1538-1548.
330. Thomson R.B., Mentone S., Kim R., Earle K., Delpire E., Somlo S., Aronson P.S. Histopathological analysis of renal cystic epithelia in the Pkd2WS25/- mouse model of ADPKD. Am J Physiol Renal Physiol 2003, 285:F870-F880.
331. Torra R., Badenas C., Darnell A., Nicolau C., Volpini V., Revert L., Estivill X. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J Am Soc Nephrol 1996, 7:2142-2151.
332. Torra R., Badenas C., Perez-Oller L., Luis J., Millan S., Nicolau C., Oppenheimer F., Mila M., Darnell A. Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients. Am J Kidney Dis 2000, 36:728-734.
333. Torra R., Badenas C., San Millan J.L., Perez-Oller L., Estivill X., Darnell A. A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2. Am J Hum Genet 1999, 65:345-352.
334. Torres V.E., Cai Y., Chen X., Wu G.Q., Geng L., Cleghorn K.A., Johnson C.M., Somlo S. Vascular expression of polycystin 2. J Am Soc Nephrol 2001, 12:1-9.
335. Torres V.E., Donovan K.A., Scicli G., Holley K.E., Thibodeau S.N., Carretero O.A., Inagami T., McAteer J.A., Johnson C.M. Synthesis of renin by tubulocystic epithelium in autosomaldominant polycystic kidney disease. Kidney Int 1992, 42:364-373.
336. Torres V.E., Erickson S.B., Smith L.H., Wilson D.M., Hattery R.R., Segura J.W. The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis 1988, 11:318-325.
337. Torres V.E., Harris P.C. Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases. Nat Clin Pract Nephrol 2006, 2:40-55.
338. Torres V.E., Harris P.C., Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007, 369:1287-1301.
339. Torres V.E., Holley K.E., Offord K.P., Gardner K. General features of autosomal dominant polycystic kidney disease. Problems in Diagnosis and Management of Polycystic Kidney Disease 1985, 49-69. PKD Foundation, Kansas City. J. Grantham (Ed.).
340. Torres V.E., King B.F., Chapman A., Brummer M.E., Bae K.T., et al. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. CJASN 2007, 2:112-120.
341. Torres V.E., Wang X., Qian Q., Somlo S., Harris P.C., Gattone V.H. Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat Med 2004, 10:363-364.
342. Torres V.E., Wilson D.M., Burnett J.C., Johnson C.M., Offord K.P. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease. Mayo Clin Proc 1991, 66:1010-1017.
343. Torres V.E., Wilson D.M., Hattery R.R., Segura J.W. Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1993, 22:513-519.
344. Torres V., Rastogi S., King B., Stanson A., Gross J., Nagorney D. Hepatic venous outflow obstruction in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1994, 5:1186-1192.
345. Torres V., Wilson D.M., Offord K., Burnett J., Romero J. Natriuretic response to volume expansion in polycystic kidney disease. Mayo Clin Proc 1989, 64:509-515.
346. Treml K., Meimaroglou D., Hentges A., Bause E. The alpha- and beta-subunits are required for expression of catalytic activity in the hetero-dimeric glucosidase Iicomplex from human liver. Glycobiology 2000, 10:493-502.
347. Trombetta E.S., Simons J.F., Helenius A. Endoplasmic reticulum glucosidase II is composed of a catalytic subunit, conserved from yeast to mammals, and a tightly bound noncatalytic HDEL-containing sub. J Biol Chem 1996, 271:27509-27516.
348. Tsiokas L., Arnould T., Zhu C., Kim E., Walz G., Sukhatme V.P. Specific association of the gene product of PKD2 with the TRPC1 channel. Proc Natl Acad Sci U S A 1999, 96:3934-3939.
349. Tsiokas L., Kim E., Arnould T., Sukhatme V.P., Walz G. Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci U S A 1997, 94:6965-6970.
350. Veldhuisen B., Spruit L., Dauwerse H.G., Breuning M.H., Peters D.J.M. Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2). Eur J Hum Genet 1999, 7:860-872.
351. Wahl P.R., Serra A.L., Le Hir M., Molle K.D., Hall M.N., Wuthrich R.P. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Nephrol Dial Transplant 2006, 21:598-604.
352. Wakai K., Nakai S., Kikuchi K., Iseki K., Miwa N., Masakane I., Wada A., Shinzato T., Nagura Y., Akiba T. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause. Nephrol Dial Transplant 2004, 19:2044-2052.
353. Wallace D.P., Rome L.A., Sullivan L.P., Grantham J.J. cAMP-dependent fluid secretion in rat inner medullary collecting ducts. Am J Physiol Renal Physiol 2001, 280:1019-1029.
354. Wallingford J.B. Planar cell polarity, ciliogenesis and neural tube defects. Hum Mol Genet 2006, 15:R227-R234. [Spec No. 2].
355. Walz G. Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): is there light at the end of the tunnel?. Nephrol Dial Transplant 2006, 21:1752-1757.
356. Wang D., Iversen J., Wilcox C.S., Strandgaard S. Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease. Kidney Int 2003, 64:1381-1388.
357. Wang S., Zhang J., Nauli S.M., Li X., Starremans P.G., Luo Y., Roberts K.A., Zhou J. Fibrocystin/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia. Mol Cell Biol 2007, 27:3241-3252.
358. Wang X., Gattone V.H., Harris P.C., Torres V.E. Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol 2005, 16:846-851.
359. Wang Y., Nathans J. Tissue/planar cell polarity in vertebrates: new insights and new questions. Development 2007, 134:647-658.
360. Ward C.J., Hogan M.C., Rossetti S., Walker D., Sneddon T., Wang X., Kubly V., Cunningham J.M., Bacallao R., Ishibashi M., Milliner D.S., Torres V.E., Harris P.C. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 2002, 30:259-269.
361. Ward C.J., Turley H., Ong A.C., Comley M., Biddolph S., Chetty R., Ratcliffe P.J., Gattner K., Harris P.C. Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc Natl Acad Sci U S A 1996, 93:1524-1528.
362. Ward C.J., Yuan D., Masyuk T.V., Wang X., Punyashthiti R., Whelan S., Bacallao R., Torra R., LaRusso N.F., Torres V.E., Harris P.C. Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia. Hum Mol Genet 2003, 12:2703-2710.
363. Watnick T., He N., Wang K., Liang Y., Parfrey P., Hefferton D., George-Hyslop P., Germino G., Pei Y. Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations. Nat Genet 2000, 25:143-144.
364. Watnick T., Phakdeekitcharoen B., Johnson A., Gandolph M., Wang M., Briefel G., Klinger K.W., Kimberling W., Gabow P., Germino G.G. Mutation detection of PKD1 Identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease. Am J Hum Genet 1999, 65:1561-1571.
365. Watnick T.J., Jin Y., Matunis E., Kernan M.J., Montell C. A flagellar polycystin-2 homolog required for male fertility in Drosophila. Curr Biol 2003, 13:2179-2184.
366. Watnick T.J., Torres V.E., Gandolph M.A., Qian F., Onuchic L.F., Klinger K.W., Landes G., Germino G.G. Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease. Mol Cell 1998, 2:247-251.
367. Watnick T., Piontek K., Cordal T., Weber H., Gandolph M., Qian F., Lens X., Neumann H., Germino G. An unusual pattern of mutation in the duplicated portion of PKD1 is revealed by use of a novel strategy for mutation detection. Hum Mol Genet 1997, 6:1473-1481.
368. Watson M., MacNicol A., Allan P., Wright A. Effects of angiotensin-converting enzyme inhibition in adult polycystic kidney disease. Kidney Int 1992, 41:206-210.
369. Wijdicks E.F., Torres V.E., Schievink W.I. Chronic subdural hematoma in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2000, 35:40-43.
370. Wilson P.D. Polycystic kidney disease. N Engl J Med 2004, 350:151-164.
371. Wilson P.D., Geng L., Li X., Burrow C.R. The PKD1 gene product, "polycystin-1," is a tyrosinephosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal. Lab Invest 1999, 79:1123-1311.
372. Wilson S.J., Amsler K., Hyink D.P,., Li X., Lu W., Zhou J., Burrow C.R., Wilson P.D. Inhibition of HER-2(neu/ErbB2) restores normal function and structure to polycystic kidney disease (PKD) epithelia. Biochim Biophys Acta 2006, 1762:647-655.
373. Witzgall R. Polycystin-2-an intracellular or plasma membrane channel?. Naunyn Schmiedebergs Arch Pharmacol 2005, 371:342-347.
374. Woo D. Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 1995, 333:18-25.
375. Woods A.J., White D.P., Caswell P.T., Norman J.C. PKD1/PKCmu promotes alphavbeta3 integrin recycling and delivery to nascent focal adhesions. EMBO J 2004, 23:2531-2543.
376. Wu G., D'Agati V., Cai Y., Markowitz G., Park J.H., Reynolds D.M., Maeda Y., Le T.C., Hou H.J., Kucherlapati R., Edelmann W., Somlo S. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 1998, 93:177-188.
377. Wu G., Markowitz G.S., Li L., D'Agati V.D., Factor S.M., Geng L., Tibara S., Tuchman J., Cai Y., Park J.H., van Adelsberg J., Hou H., Kucherlapati R., Edelmann W., Somlo S. Cardiac defects and renal failure in mice with targeted mutations in Pkd2. Nat Genet 2000, 24:75-78.
378. Wu G., Tian X., Nishimura S., Markowitz G.S., D'Agati V., Hoon P.J., Yao L., Li L., Geng L., Zhao H., Edelmann W., Somlo S. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease. Hum Mol Genet 2002, 11:1845-1854.
379. Wu G.Q., Hayashi T., Park J.H., Dixit M.P., Reynolds D.M., Li L., Cai Y., Coca-Prados M., Somlo S. Identification of the human PKD2-related cDNA, PKD2L: tissue-specific expression and linkage mapping on chromosome 10q25. Genomics 1998, 54:564-568.
380. Wu Y., Dai X.Q., Li Q., Chen C.X., Mai W., Hussain Z., Long W., Montalbetti N., Li G., Glynne R., Wang S., Cantiello H.F., Wu G., Chen X.Z. Kinesin-2 mediates physical and functional interactions between polycystin-2 and fibrocystin. Hum Mol Genet 2006, 15:3280-3292.
381. Xu G.M., Sikaneta T., Sullivan B.M., Zhang Q., Andreucci M., Stehle T., Drummond I., Arnaout M.A. Polycystin-1 interacts with intermediate filaments. J Biol Chem 2001, 276:46544-46552.
382. Xu N., Glockner J.F., Rossetti S., Babovich-Vuksanovic D., Harris P.C., Torres V.E. Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis. J Nephrol 2006, 19:529-534.
383. Yamaguchi T., Nagao S., Wallace D.P., Belibi F.A., Cowley B.D., Pelling J.C., Grantham J.J. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int 2003, 63:1983-1994.
384. Yamaguchi T., Pelling J.C., Ramaswamy N.T., Eppler J.W., Wallace D.P., Nagao S., Rome L.A., Sullivan L.P., Grantham J.J. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int 2000, 57:1460-1471.
385. Yamaguchi T., Wallace D.P., Magenheimer B.S., Hempson S.J., Grantham J.J., Calvet J.P..ti]Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMPdependent growth-stimulated phenotype J Biol Chem 2004, 279:40419-40430.
386. Yap A.S., Brieher W.M., Gumbiner B.M. Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol 1997, 13:119-146.
387. Yeaman C., Grindstaff K.K., Nelson W.J. New perspectives on mechanisms involved in generating epithelial cell polarity. Physiol Rev 1999, 79:73-98.
388. Yen H.J., Tayeh M.K., Mullins R.F., Stone E.M., Sheffield V.C., Slusarski D.C. Bardet-Biedl syndrome genes are important in retrograde intracellular trafficking and Kupffer's vesicle cilia function. Hum Mol Genet 2006, 15:667-677.
389. Yium J., Gabow P., Johnson A., Kimberling W., Martinez-Maldonado M. Autosomal dominant polycystic kidney disease in blacks: clinical course and effects of sickle-cell hemoglobin. J Am Soc Nephrol 1994, 4:1670-1674.
390. Yoder B.K., Hou X., Guay-Woodford L.M. The polycystic kidney disease proteins, polycystin- 1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J Am Soc Nephrol 2002, 13:2508-2516.
391. Yuasa T., Venugopal B., Weremowicz S., Morton C.C., Guo L., Zhou J. The sequence, expression, and chromosomal localization of a novel polycystic kidney disease 1-like gene, PKD1L1, in human. Genomics 2002, 79:376-386.
392. Zerres K., Mucher G. Autosomal recessive polycystic kidney disease. J Mol Med 1998, 76:303-309.